自然杀手细胞的表面工程与CD44向性联体用于增强癌症免疫疗法
Sungjun Kim1, Shujin Li2, Ashok Kumar Jangid1
1Department of Chemical & Biochemical Engineering, Dongguk University, 30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea.
Small (Weinheim an der Bergstrasse, Germany)
|December 31, 2023
概括
工程自然杀手 (NK) 细胞,覆盖氨酸-聚乙烯糖醇-脂质 (HA-PEG-Lipid),通过识别CD44过度表达的癌细胞,有效地准固体瘤. 这种新的方法可以增强NK细胞免疫治疗固体瘤的免疫疗法,而无需进行遗传修饰.
科学领域:
- 生物技术是生物技术.
- 免疫治疗是一种免疫疗法.
- 材料科学 材料科学 材料科学
背景情况:
- 使用自然杀手 (NK) 细胞的采用免疫疗法对血液癌症具有前景.
- 用NK细胞治疗固体瘤受到低瘤特异性抗原表达的限制.
研究的目的:
- 开发一种非遗传方法来增强固体瘤的NK细胞向.
- 用氨酸 (HA) 设计NK细胞,以实现CD44受体介导的癌细胞识别.
主要方法:
- 用脂质-PEG结合氨酸 (HA-PEG-Lipid) 生物材料对NK细胞的表面涂层.
- 利用疏水性相互作用在NK细胞上进行膜定和HA呈现.
- 在试验室和老鼠异种移植固体瘤模型中评估HANK细胞的疗效.
主要成果:
- 工程HANK细胞选择性地与CD44过度表达的胰腺癌细胞结合并激活.
- 与未经修改的NK细胞和体内体内的gemcitabine相比,HANK细胞表现出优异的瘤透,亡诱导和瘤抑制.
- 通过HANK细胞成功建立免疫突触并随后消除癌细胞.
结论:
- HA-PEG-Lipid生物材料提供了一个非遗传策略,用于为固体瘤免疫疗法设计NK细胞.
- 表面工程HANK细胞表现出有效消除癌症的"识别激活"机制.
- 这种方法为推进基于NK细胞的免疫疗法对抗固体瘤提供了一个有希望的途径.
更多相关视频
11:02Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line
Published on: February 8, 2022
5.6K
08:50Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
724
相关概念视频
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cytotoxic T Cells-mediated Immune Response
923
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
923
Immune Surveillance by NK Cells and Phagocytes
1.4K
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
1.4K
